Nothing Special   »   [go: up one dir, main page]

Nishio et al., 1990 - Google Patents

Fecal IgA antibody responses after oral poliovirus vaccination in infants and elder children

Nishio et al., 1990

View PDF
Document ID
4997223750778282302
Author
Nishio O
Sumi J
Sakae K
Ishihara Y
Isomura S
Inouye S
Publication year
Publication venue
Microbiology and immunology

External Links

Snippet

We investigated fecal IgA antibody responses after oral polyvalent poliovirus vaccination. Infants were given vaccines twice with an interval of 6 weeks. Specific IgA antibodies in the feces were determined by enzyme‐linked immunosorbent assay, and viruses were isolated …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1036—Retroviridae, e.g. leukemia viruses

Similar Documents

Publication Publication Date Title
Coulson et al. Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses
Cukor et al. Human viral gastroenteritis
Onorato et al. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines
Takano et al. Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection
Emini et al. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies
Foster et al. Gastroenteritis due to rotavirus in an isolated Pacific island group: an epidemic of 3,439 cases
Jing et al. Seroprevalence against Norwalk‐like human caliciviruses in Beijing, China
Cukor et al. Detection of rotavirus in human stools by using monoclonal antibody
Heinz et al. A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus
Wright et al. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation
de Matancourt et al. Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome
Taniguchi et al. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination
Watt et al. Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants
Nishio et al. Fecal IgA antibody responses after oral poliovirus vaccination in infants and elder children
Swanink et al. Coxsackievirus B1-based antibody-capture enzyme-linked immunosorbent assay for detection of immunoglobulin G (IgG), IgM, and IgA with broad specificity for enteroviruses
Langedijk et al. Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G
Yao et al. Antibody-dependent enhancement of hantavirus infection in macrophage cell lines
Midthun et al. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants
Ho-Terry et al. Immunological characterisation of the rubella E 1 glycoprotein
TSUTSUMI et al. Different kinetics of antibody responses between IgA and IgG classes in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection
Sato et al. Sensitive neutralization test for virus antibody: 1. Mumps antibody
Tamura et al. Virus excretion and neutralizing antibody response in saliva in human cytomegalovirus infection
Arias et al. Neutralizing antibody immune response in children with primary and secondary rotavirus infections
Ranz et al. Diagnostic methods for African horsesickness virus using monoclonal antibodies to structural and non-structural proteins
Tanaka et al. High Efficiency Cross‐Reactive Monoclonal Antibody Production by Oral Immunization with Recombinant Norwalk Virus‐Like Particles